BIO Products Spółka z Ograniczoną Odpowiedzialnością (KRS 0000986552, NIP 7011100430) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. BIO PRODUCTS operates in: Non-specialised wholesale of food, beverages and tobacco (PKD 46.39.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since August 9, 2022. BIO PRODUCTS's most recently reported net revenue was 122.7 K PLN for 2023.
Negative equity
Negative equity in 1 of 1 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - BIO Products
Identity
- Name
- BIO Products Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- August 9, 2022
- Registry status as of
- December 17, 2025
- Latest entry
- December 16, 2025
- Founding act
- 05.08.2022
Articles of association history (1)
- August 5, 2022: 05.08.2022
Activities
Main activity
46.39.ZNon-specialised wholesale of food, beverages and tobacco
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- ALEJA BOHATERÓW WRZEŚNIA, 18, 42, 02-389, WARSZAWA, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- WARSZAWA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.2298, 21.0117approx.
Risk and payment profile - BIO Products
Credibility rating
13.5 / 100
Very poor credibility
Insolvency risk
High
Significant formal threat
Closure risk
37
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
Spółka wykazuje sygnały niestabilności organizacyjnej: częste zmiany właścicieli. Może to wskazywać na podwyższone ryzyko współpracy.
Shareholder changes
2
2/4 yrs
Board changes
2
2/4 yrs
PKD changes
0
0/4 yrs
Name changes
0
0/4 yrs
Data from 4 years of registry activity.
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - BIO Products
Founded
August 9, 2022
3 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
46.39.Z
Non-specialised wholesale of food, beverages and tobacco
Share capital
5.0 K PLN
100 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
1 year
2023 · profitable: 0/1
Registry entries
9
latest: December 16, 2025
Risk signals
Revenue
122.7 K PLN
2023
Net profit
-85.3 K PLN
2023
Assets
116.8 K PLN
2023
Equity
-80.3 K PLN
2023
Valuation
47.3 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - BIO Products.
No ratings
Related articles
Explainer
Eurocash in 2026: Polish FMCG-wholesale leader and Delikatesy Centrum network, an mWIG40 issuer near Poznań, controlled by Luis Amaral
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral, listed on the WSE since 2005, the company is an mWIG40 constituent. A six-member management board, a five-member supervisory board, chaired by the founder himself.
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
